PharmaTher Holdings Ltd. (PHRRF)
USD 0.14
(2.99%)
USD 0.14
(2.99%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -3.04 Million CAD | -120.35% |
| 2023 | -1.38 Million CAD | 65.19% |
| 2022 | -3.96 Million CAD | 53.43% |
| 2021 | -8.52 Million CAD | -35680.49% |
| 2020 | -23.82 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.34 Million CAD | -123.33% |
| 2024 Q4 | -386.27 Thousand CAD | -93157.36% |
| 2024 Q3 | -414.20 CAD | 99.94% |
| 2024 Q2 | -735.43 Thousand CAD | 45.13% |
| 2023 Q1 | -655 Thousand CAD | 76.3% |
| 2023 FY | -1.38 Million CAD | 65.19% |
| 2023 Q4 | -600.18 Thousand CAD | 27.59% |
| 2023 Q3 | -828.9 Thousand CAD | -217.97% |
| 2023 Q2 | 702.63 Thousand CAD | 207.27% |
| 2022 Q4 | -2.76 Million CAD | -426.56% |
| 2022 Q3 | 846.34 Thousand CAD | 143.69% |
| 2022 Q2 | -1.93 Million CAD | -1592.16% |
| 2022 Q1 | -114.47 Thousand CAD | 74.18% |
| 2022 FY | -3.96 Million CAD | 53.43% |
| 2021 Q4 | -443.32 Thousand CAD | 93.45% |
| 2021 FY | -8.52 Million CAD | -35680.49% |
| 2021 Q3 | -6.76 Million CAD | -480.3% |
| 2021 Q2 | -1.16 Million CAD | -242.44% |
| 2021 Q1 | -340.61 Thousand CAD | 0.0% |
| 2020 FY | -23.82 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| ContraFect Corporation | -56.88 Million USD | 94.649% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -17373.624% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -10063.194% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -226.835% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 95.76% |
| Kadimastem Ltd | -3.04 Million USD | -0.126% |
| Zenith Capital Corp. | -8.94 Million USD | 65.961% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -63.277% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -11994.08% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 54.211% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -1063.079% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -117.126% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 103.719% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -98.176% |
| Qrons Inc. | -643.67 Thousand USD | -372.92% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -92.742% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -23.979% |
| Accustem Sciences Inc. | -3.74 Million USD | 18.747% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -530.163% |
| Affymax, Inc. | -15.04 Million USD | 79.768% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 94.463% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 39.655% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -10.66% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -127.947% |
| Biomind Labs Inc. | -1 Million USD | -201.513% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -142.363% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -15.854% |
| CytoDyn Inc. | -18.05 Million USD | 83.143% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 82.943% |
| IMV Inc. | -38.67 Million USD | 92.128% |
| Genus plc | 6.4 Million USD | 147.564% |
| Halberd Corporation | -75.05 Thousand USD | -3956.069% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -209.341% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 161.937% |
| LadRx Corporation | -3.82 Million USD | 20.388% |
| Marizyme, Inc. | -34.08 Million USD | 91.07% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -1283.182% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 185.991% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 33.167% |
| Q BioMed Inc. | -3.44 Million USD | 11.654% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -343.13% |
| Enzolytics Inc. | -2.14 Million USD | -41.664% |
| CSL Limited | 3.7 Billion USD | 100.082% |
| Skye Bioscience, Inc. | -13.67 Million USD | 77.735% |
| SQZ Biotechnologies Company | -75.82 Million USD | 95.985% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -53.24% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 131.245% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -1674.875% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -4.269% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -191.579% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 63.544% |
| NovAccess Global Inc. | -2.46 Million USD | -23.404% |
| HST Global, Inc. | -140.9 Thousand USD | -2060.347% |
| SYBLEU INC | -149.18 Thousand USD | -1940.542% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 94.84% |
| Alpha Cognition Inc. | -9.7 Million USD | 68.636% |
| AVAX Technologies, Inc. | 6.69 Million USD | 145.482% |
| Mesoblast Limited | -84.14 Million USD | 96.382% |
| MultiCell Technologies, Inc. | -722.81 USD | -421045.253% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -6.791% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 80.818% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -681.395% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | 37.615% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -57.511% |
| GB Sciences, Inc. | -1.42 Million USD | -114.295% |
| argenx SE | -425.04 Million USD | 99.284% |
| Resverlogix Corp. | -12.74 Million USD | 76.123% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 3.92% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 94.516% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -4.923% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 10.599% |
| ONE Bio Corp. | 13.68 Million USD | 122.25% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.268% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -51.843% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -170.607% |
| Agentix Corp. | -1.37 Million USD | -121.911% |
| Adynxx, Inc. | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | 60.868% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -1577.318% |
| Cell Source, Inc. | -4.32 Million USD | 29.622% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -632.668% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -343.13% |
| Itoco Inc. | -919.14 Thousand USD | -231.188% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 28.179% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -172.036% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -439.039% |
| Nascent Biotech, Inc. | -2.22 Million USD | -36.513% |
| Rebus Holdings, Inc. | -664 Thousand USD | -358.446% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -67.596% |
| Mobile Lads Corp. | -554.55 Thousand USD | -448.928% |
| International Stem Cell Corporation | -663 Thousand USD | -359.137% |
| Bioxytran, Inc. | -3.82 Million USD | 20.315% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -5682.827% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -14865.978% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 91.606% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -88.138% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -313.691% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 2.151% |
| Neutra Corp. | -229.48 Thousand USD | -1226.477% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 82.644% |
| PureTech Health plc | -146.19 Million USD | 97.918% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 85.836% |
| IXICO plc | -1.43 Million USD | -111.836% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 67.927% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 97.501% |
| CSL Limited | 3.81 Billion USD | 100.08% |
| Cellectis S.A. | -108.85 Million USD | 97.204% |